Positions

Assistant Professor

Molecular and Human Genetics
Baylor College of Medicine
Houston, United States
Molecular Oncology

Member

Dan L. Duncan Cancer Center
Houston

Addresses

Jan and Dan Duncan Neurological Research Institute (Lab)

1250 Moursund Street
Houston, TX 77030
United States
Phone: (832) 824-8888
tiemo.klisch@bcm.edu

Education

PhD from International Max Planck Research School

08/2006 - Göttingen, Germany

BSc from Georg-August-University

04/2003 - Göttingen, Germany

Fellowship at Ehime University

09/2000 - Matsuyama, Japan

Fellowship at Albert Ludwig University

09/1999 - Freiburg, Germany

Professional Statement

Brain tumors are a diverse group of neoplasms arising from different cells of the central nervous system. Although brain tumors account for only 2 percent of all cancers, these neoplasms result in a disproportionate share of cancer morbidity and mortality of 5.8 per 100,000 population (annual age-adjusted mortality rate in the US 2008-2012). My lab focuses on the causes and biological differences of adult meningioma.

Meningiomas account for almost 40% of all primary brain tumors with 2.5 times higher occurrence in women and African-Americans compared with men and other ethnicities. The total number of meningioma patients who fail treatment or experience uncontrolled local recurrence represent roughly two-thirds of all meningioma patients. Even benign meningiomas are lethal if located in an inaccessible region. Over the past decade, Dr. Patel’s and my lab have been first to discover the three true biological groups that give rise to meningioma, with one being exclusively responsible for the most aggressive type of meningioma. Our studies have been independently validated by multiple other laboratories, which has led to close collaborations throughout the world.

We are part of the International Meningioma Database and contribute as editors to BMC Cancer and Frontiers in Neuroscience.

For job opportunities and future collaboration, please do not hesitate to contact us.

Websites

Selected Publications

• Labs of Sahm (DKFZ), Bi (Harvard), Klisch (BCM), Patel (BCM), Magill (Northwestern), Raleigh (UCSF), and others "Targeted gene expression profiling predicts meningioma outcomes and radiotherapy responses.." Nature Medicine. 2023; Pubmed PMID: 36993741
• Khan AB, English CW, Bayley V JC, Brandt VL, Shetty A, Hadley CC, Choudhury A, Lu HC, Harmanci AS, Harmanci AO, Magill ST, Raleigh DR, Klisch TJ, Patel AJ "Even heterozygous loss of CDKN2A/B greatly accelerates recurrence in aggressive meningioma.." Acta Neuropathologica. 2023; Pubmed PMID: 36729132
• Khan AB, Patel R, McDonald MF, Goethe E, English C, Gadot R, Shetty A, Nouri SH, Harmanci AO, Harmanci AS, Klisch TJ, Patel AJ "Integrated clinical genomic analysis reveals xenobiotic metabolic genes are downregulated in meningiomas of current smokers." J Neurooncol. 2023; Pubmed PMID: 37318677
• Harmanci AO, Harmanci AS, Klisch TJ, Patel AJ "XCVATR: Detection and Characterization of Variant Impact on the Embeddings of Single-Cell and Bulk RNA-Sequencing Samplesulk RNA-Sequencing Samples." BMC genomics. 2022; Pubmed PMID: 36539717